Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial
PaperCitations, authors & open-access status
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 358 citations, 2019 year and hybrid oa status.
358
Citations
2019
Year
hybrid
OA Status